Impact of continuous care on cardiac function in patients with lung cancer complicated by coronary heart disease

Table 4 Comparison between groups of patients in terms of Seattle Angina Questionnaire and medication compliance

Variables	Control group (n = 38)	Intervention group (n = 41)	P value
SAQ-PL
Before	59.89 ± 8.68	60.11 ± 11.16	0.92
After	62.29 ± 9.73	72.46 ± 10.51	< 0.001
P value	0.26	< 0.001
SAQ-AS
Before	53.25 ± 8.03	54.09 ± 10.66	0.69
After	59.71 ± 7.68	70.13 ± 11.19	< 0.001
P value	< 0.001	< 0.001
SAQ-AF
Before	66.78 ± 6.29	65.74 ± 7.80	0.51
After	79.87 ± 4.65	84.52 ± 9.91	0.01
P value	< 0.001	< 0.001
SAQ-TS
Before	74.91 ± 7.75	76.57 ± 8.02	0.35
After	80.08 ± 9.20	87.91 ± 9.96	< 0.001
P value	0.009	< 0.001
SAQ-DP
Before	68.22 ± 7.54	68.26 ± 8.27	0.98
After	75.17 ± 6.18	82.02 ± 6.01	< 0.001
P value	< 0.001	< 0.001
Medication compliance	7.42 ± 1.96	9.46 ± 2.99	< 0.001

SAQ: Seattle Angina Questionnaire.